149 related articles for article (PubMed ID: 30952971)
1. Cytomegalovirus reactivation in inflammatory bowel disease: an uncommon occurrence related to corticosteroid dependence.
Hissong E; Chen Z; Yantiss RK
Mod Pathol; 2019 Jul; 32(8):1210-1216. PubMed ID: 30952971
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.
Pillet S; Pozzetto B; Roblin X
World J Gastroenterol; 2016 Feb; 22(6):2030-45. PubMed ID: 26877608
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
Hradsky O; Copova I; Zarubova K; Durilova M; Nevoral J; Maminak M; Hubacek P; Bronsky J
Dig Dis Sci; 2015 Nov; 60(11):3399-407. PubMed ID: 26091801
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis.
Franklin C; Rooms I; Fiedler M; Reis H; Milsch L; Herz S; Livingstone E; Zimmer L; Schmid KW; Dittmer U; Schadendorf D; Schilling B
Eur J Cancer; 2017 Nov; 86():248-256. PubMed ID: 29055840
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a multiplex PCR assay for detection of cytomegalovirus in stool samples from patients with ulcerative colitis.
Nahar S; Iraha A; Hokama A; Uehara A; Parrott G; Ohira T; Kaida M; Kinjo T; Kinjo T; Hirata T; Kinjo N; Fujita J
World J Gastroenterol; 2015 Nov; 21(44):12667-75. PubMed ID: 26640344
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status.
Inokuchi T; Kato J; Hiraoka S; Suzuki H; Nakarai A; Hirakawa T; Akita M; Takahashi S; Harada K; Okada H; Yamamoto K
World J Gastroenterol; 2014 Jan; 20(2):509-17. PubMed ID: 24574719
[TBL] [Abstract][Full Text] [Related]
7. Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease.
Ma C; Walters B; Fedorak RN
World J Gastroenterol; 2013 Jun; 19(21):3347-51. PubMed ID: 23745038
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis: effect of antiviral treatment.
Maconi G; Lombardini M; Furfaro F; Bezzio C; Zerbi P; Ardizzone S
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1146-51. PubMed ID: 25089547
[TBL] [Abstract][Full Text] [Related]
9. Management of cytomegalovirus infection in inflammatory bowel diseases.
Pillet S; Pozzetto B; Jarlot C; Paul S; Roblin X
Dig Liver Dis; 2012 Jul; 44(7):541-8. PubMed ID: 22538204
[TBL] [Abstract][Full Text] [Related]
10. Preventing infective complications in inflammatory bowel disease.
Mill J; Lawrance IC
World J Gastroenterol; 2014 Aug; 20(29):9691-8. PubMed ID: 25110408
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroids and Thiopurines, But Not Tumor Necrosis Factor Antagonists, are Associated With Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Shukla T; Singh S; Tandon P; McCurdy JD
J Clin Gastroenterol; 2017; 51(5):394-401. PubMed ID: 27875356
[TBL] [Abstract][Full Text] [Related]
12. CMV in moderately active colitis: much ado about nothing?
Moss AC
Dig Dis Sci; 2010 Apr; 55(4):880-2. PubMed ID: 20204696
[No Abstract] [Full Text] [Related]
13. Evaluation of a non-invasive method to detect cytomegalovirus (CMV)-DNA in stool samples of patients with inflammatory bowel disease (IBD): a pilot study.
Herfarth HH; Long MD; Rubinas TC; Sandridge M; Miller MB
Dig Dis Sci; 2010 Apr; 55(4):1053-8. PubMed ID: 20165976
[TBL] [Abstract][Full Text] [Related]
14. The risk for opportunistic infections in inflammatory bowel disease with biologics: an update.
Borman ZA; Côté-Daigneault J; Colombel JF
Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1101-1108. PubMed ID: 30277409
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose Valacyclovir for Cytomegalovirus Infection Prophylaxis After a Heart Transplant.
Kervan U; Kucuker SA; Kocabeyoglu SS; Unal EU; Ozatik MA; Sert DE; Kavasoglu K; Tezer AY; Pac M
Exp Clin Transplant; 2016 Oct; 14(5):551-554. PubMed ID: 26976362
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases.
Kochar B; Cai W; Cagan A; Ananthakrishnan AN
Gastroenterology; 2020 Jun; 158(8):2104-2111.e2. PubMed ID: 32105728
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Low-Dose Versus Standard-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Intermediate-Risk Kidney Transplant Recipients.
Halim MA; Al-Otaibi T; Gheith O; Adel H; Mosaad A; Hasaneen AA; Zakaria Z; Makkeya Y; Said T; Nair P
Exp Clin Transplant; 2016 Oct; 14(5):526-534. PubMed ID: 27310254
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis.
Roblin X; Pillet S; Oussalah A; Berthelot P; Del Tedesco E; Phelip JM; Chambonnière ML; Garraud O; Peyrin-Biroulet L; Pozzetto B
Am J Gastroenterol; 2011 Nov; 106(11):2001-8. PubMed ID: 21788989
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection.
Maconi G; Colombo E; Zerbi P; Sampietro GM; Fociani P; Bosani M; Cassinotti A; Casini V; Russo A; Ardizzone S; Porta M; Bianchi Porro G
Dig Liver Dis; 2005 Jun; 37(6):418-23. PubMed ID: 15893280
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.
Ciccocioppo R; Racca F; Paolucci S; Campanini G; Pozzi L; Betti E; Riboni R; Vanoli A; Baldanti F; Corazza GR
World J Gastroenterol; 2015 Feb; 21(6):1915-26. PubMed ID: 25684960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
